The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for the treatment of
A recent study published in Cell Host & Microbe identifies a potential obesity-linked bacterium, Megamonas, from a large-scale cohort of obese individuals in China.
A new pathway that is used by cancer cells to infiltrate the brain has been discovered by a team of Canadian and American research groups
CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this new therapy, which was first approved in 2017 in the
Similar to other sectors around the world, the light speed development of artificial intelligence (AI) has made its way into healthcare, particularly the radiology field.
A special committee of 23andMe’s board of directors said Friday it was “disappointed” in a proposal by CEO Anne Wojcicki to take the company private.
Philips filed a lawsuit Monday against PSN Labs, claiming the company made mistakes in its risk analysis of the soundproofing foam used in Philips’ sleep
Kevin Strange, incoming Inari Medical CFO Permission granted by Inari Medical Name: Kevin Strange New title: CFO, Inari Medical Previous title: Senior vice president of
Name: Daniel Wilson New title: CFO, iRhythm Technologies Previous title: Executive vice president of corporate development and investor relations, iRhythm Daniel Wilson will become CFO
TerrAscend Completes $140 Million Debt Financing Non-dilutive financing bears a coupon of 12.75% with a four-year term and no prepayment penalties No material debt maturing